Mass screening program for prostatic cancer in Japan

International Journal of Clinical Oncology

Volumn 6, Issue 2, 2001, Pages 66-73

  Watanabe, H ^a  

^a MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

Author keywords

Filter paper method; Mass screening; Prostatic cancer; PSA; Transrectal power Doppler sonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ANTIGEN DETECTION; BIOPSY TECHNIQUE; BLOOD SAMPLING; CANCER SCREENING; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

BIOPSY; CULTURAL CHARACTERISTICS; FALSE POSITIVE REACTIONS; HUMANS; INCIDENCE; JAPAN; MALE; MASS SCREENING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0035004203     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Mass screening program for prostatic cancer in Japan
2. Purification of a human prostate specific antigen
3. Screening decreases prostate cancer death: First analysis of the 1988 Quebec prospective randomized controlled trial
4. Screening and early hormonal treatment of prostate cancer are accumulating strong evidence and support
5. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute
6. Prostate cancer screening trials: Fending off critics to recruitmen
7. The European randomized study of screening for prostate cancer
8. Trend of cancer death in the world
9. Incidental prostatic carcinoma: Morphometry correlated with histological grade
10. Epidemiological study of prostatic cancer by matched-pair analysis
11. A case-control study of prostatic cancer with reference to dietary habits
12. Natural history and prevention of prostatic cancer
13. Natural history of prostatic cancer
14. Age standardized incidence rates for cancer by each site, by sex and by race (Japan, Hawaii Japanese and US whites)
15. Prediction of cancer death in Japan
16. Mass screening program for prostatic diseases with transrectal ultrasonotomography
17. Diagnostic application of transrectal ultrasonotomography for the prostate
18. Transrectal ultrasonotomography of the prostate
19. A mobile mass screening unit for prostatic disease
20. Long term follow-up of mass screening for prostate carcinoma in men with initial prostate-specific antigen levels of 4.0ng/ml or less
21. The efficacy of prostatic cancer screening in view of death reduction
22. Present status of prostatic mass screening in Japan
23. Comparison of various assay systems for prostate-specific antigen standardization
24. Panel discussion: Index of prostatic cancer in daily clinical works
25. A case-control study on the efficacy and the optimum interval of mass screening for prostatic cancer
26. PSA assay of dried blood samples from the ear lobe on a filter paper with special reference to prostatic mass screening
27. Random systematic versus directed ultrasound-guided transrectal core biopsies of the prostate
28. Prostate-specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer
29. A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
30. The urinary bladder and the prostate
31. Ultrasonically guided puncture for the prostate and seminal vesicles with transrectal real-time linear scanner
32. Ultrasonically guided precise needle placement in the prostate and seminal vesicles
33. A preliminary study on prostate cancer detection using microscope images of prostatic needle biopsy tissues stained with PSA
34. Ultrasonic power Doppler imaging for prostatic cancer: A preliminary report
35. Transrectal power Doppler imaging in the detection of prostate cancer